Atlas Trials

Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses

Clinical trial NCT01779102 · COMPLETED

Trial details

NCT number
NCT01779102
Sponsor
Statens Serum Institut
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Tuberculosis
Start date
2013-10-01
Primary completion
2014-09-01
Enrollment
456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.